PUBLISHER: KBV Research | PRODUCT CODE: 1768303
PUBLISHER: KBV Research | PRODUCT CODE: 1768303
North America Artificial Intelligence In Cardiology Market Size, Share & Industry Analysis Report By Component, By Application, . By Medical Condition, By Country and Growth Forecast, 2025 - 2032
The North America Artificial Intelligence In Cardiology Market would witness market growth of 31.7% CAGR during the forecast period (2025-2032).
The US market dominated the North America Artificial Intelligence In Cardiology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $5,768.5 million by 2032. The Canada market is experiencing a CAGR of 35% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 33.7% during (2025 - 2032).
Artificial Intelligence (AI) is reshaping the landscape of cardiology, heralding a transformative era in cardiovascular healthcare by leveraging advanced computational techniques to enhance diagnostic precision, optimize treatment strategies, and improve patient outcomes. The integration of AI into cardiology is driven by the urgent need to address the global burden of cardiovascular diseases (CVDs), which remain the leading cause of morbidity and mortality worldwide.
AI's applications in cardiology span a wide range of clinical and research domains, revolutionizing how cardiovascular conditions are diagnosed, monitored, and treated. One of the most prominent applications is in diagnostic imaging, where AI-powered algorithms enhance the interpretation of echocardiograms, computed tomography (CT) scans, magnetic resonance imaging (MRI), and nuclear imaging. These tools analyze complex imaging data to detect conditions such as coronary artery disease (CAD), valvular heart disease, and cardiomyopathies with remarkable accuracy.
North America represents one of the most advanced and rapidly evolving markets for Artificial Intelligence (AI) in Cardiology, driven by a confluence of technological innovation, robust healthcare infrastructure, and a high prevalence of cardiovascular diseases. The region comprises major markets like the United States, Canada, and Mexico, alongside smaller but emerging markets in the Caribbean and Central America. Cardiovascular diseases remain a leading cause of death across North America, underscoring the critical need for improved diagnostic accuracy, timely interventions, and personalized treatment options.
AI technologies-including machine learning, deep learning, natural language processing, and predictive analytics-are increasingly integrated into cardiology to enhance clinical decision-making, automate image interpretation, and facilitate remote patient monitoring. The adoption of AI is supported by significant investments from both the public and private sectors, with a strong emphasis on research and development, regulatory frameworks, and collaborations between healthcare providers and technology firms. Market trends in this region focus on adoption of AI-enabled portable diagnostic devices, mobile health applications, and cloud-based platforms for cardiac data analysis.
Many healthcare providers rely on partnerships with multinational technology companies and NGOs to deploy AI solutions tailored to local needs. The competitive landscape is less saturated, offering opportunities for emerging startups and foreign technology firms to establish presence. Challenges include limited regulatory frameworks, funding constraints, and workforce shortages in both cardiology and AI specialties. Nonetheless, increasing government interest in digital transformation and healthcare modernization projects suggest a positive trajectory. Capacity building through training and knowledge exchange is a critical enabler for market growth. In conclusion, North America stands at the forefront of leveraging AI to revolutionize cardiology care, improving patient outcomes while addressing healthcare system challenges such as cost containment and specialist shortages.
Based on Component, the market is segmented into Hardware, Software, and Services. Based on Application, the market is segmented into Diagnosis, Prediction, Drug Discovery, and Other Application. Based on Medical Condition, the market is segmented into Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- IDOVEN S.L.
- Ultromics Ltd.
- CardiAI.Inc.
- Tempus AI, Inc.
- Koninklijke Philips N.V.
- Cleerly, Inc.
- Vista AI, Inc.
- Viz.ai, Inc.
- RSIP Vision Ltd.
- GE HealthCare Technologies, Inc.
North America Artificial Intelligence In Cardiology Market Report Segmentation
By Component
- Hardware
- Software
- Services
By Application
- Diagnosis
- Prediction
- Drug Discovery
- Other Application
By Medical Condition
- Ischemic Heart Disease /CAD
- Cardiac Arrhythmias
- Heart Failure
- Other Medical Condition
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Artificial Intelligence In Cardiology Market, by Component
- 1.4.2 North America Artificial Intelligence In Cardiology Market, by Application
- 1.4.3 North America Artificial Intelligence In Cardiology Market, by Medical Condition
- 1.4.4 North America Artificial Intelligence In Cardiology Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2024
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
- 4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov - 2025, Apr) Leading Players
- 4.5 Porter Five Forces Analysis
Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
- 5.1 Research & Development (R&D):
- 5.2 Data Acquisition & Management:
- 5.3 Model Development & Training:
- 5.4 Regulatory Approval & Certification:
- 5.5 Product Integration & Deployment:
- 5.6 Marketing & Sales:
- 5.7 After-Sales Support & Feedback Loop:
Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
- 6.1 Diagnostic Accuracy
- 6.2 Regulatory Compliance
- 6.3 Data Privacy and Security
- 6.4 Integration with Existing Healthcare Systems
- 6.5 Clinical Validation and Peer-Reviewed Evidence
- 6.6 Ease of Use and Interface Design
- 6.7 Real-Time Processing and Speed
- 6.8 Cost-Effectiveness and Return on Investment (ROI)
- 6.9 Continuous Learning and Model Updates
- 6.10. Vendor Support and Training Services
Chapter 7. North America Artificial Intelligence In Cardiology Market by Component
- 7.1 North America Hardware Market by Country
- 7.2 North America Software Market by Country
- 7.3 North America Services Market by Country
Chapter 8. North America Artificial Intelligence In Cardiology Market by Application
- 8.1 North America Diagnosis Market by Country
- 8.2 North America Prediction Market by Country
- 8.3 North America Drug Discovery Market by Country
- 8.4 North America Other Application Market by Country
Chapter 9. North America Artificial Intelligence In Cardiology Market by Medical Condition
- 9.1 North America Ischemic Heart Disease /CAD Market by Country
- 9.2 North America Cardiac Arrhythmias Market by Country
- 9.3 North America Heart Failure Market by Country
- 9.4 North America Other Medical Condition Market by Country
Chapter 10. North America Artificial Intelligence In Cardiology Market by Country
- 10.1 US Artificial Intelligence In Cardiology Market
- 10.1.1 US Artificial Intelligence In Cardiology Market by Component
- 10.1.2 US Artificial Intelligence In Cardiology Market by Application
- 10.1.3 US Artificial Intelligence In Cardiology Market by Medical Condition
- 10.2 Canada Artificial Intelligence In Cardiology Market
- 10.2.1 Canada Artificial Intelligence In Cardiology Market by Component
- 10.2.2 Canada Artificial Intelligence In Cardiology Market by Application
- 10.2.3 Canada Artificial Intelligence In Cardiology Market by Medical Condition
- 10.3 Mexico Artificial Intelligence In Cardiology Market
- 10.3.1 Mexico Artificial Intelligence In Cardiology Market by Component
- 10.3.2 Mexico Artificial Intelligence In Cardiology Market by Application
- 10.3.3 Mexico Artificial Intelligence In Cardiology Market by Medical Condition
- 10.4 Rest of North America Artificial Intelligence In Cardiology Market
- 10.4.1 Rest of North America Artificial Intelligence In Cardiology Market by Component
- 10.4.2 Rest of North America Artificial Intelligence In Cardiology Market by Application
- 10.4.3 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition
Chapter 11. Company Profiles
- 11.1 IDOVEN S.L.
- 11.1.1 Company Overview
- 11.2 Ultromics Ltd.
- 11.2.1 Company Overview
- 11.2.2 Recent strategies and developments:
- 11.2.2.1 Partnerships, Collaborations, and Agreements:
- 11.2.2.2 Product Launches and Product Expansions:
- 11.3 CardiAI Inc.
- 11.3.1 Company Overview
- 11.4 Tempus AI, Inc.
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Research & Development Expenses
- 11.4.4 Recent strategies and developments:
- 11.4.4.1 Product Launches and Product Expansions:
- 11.4.4.2 Acquisition and Mergers:
- 11.4.5 SWOT Analysis
- 11.5 Koninklijke Philips N.V.
- 11.5.1 Company Overview
- 11.5.2 Financial Analysis
- 11.5.3 Segmental and Regional Analysis
- 11.5.4 Research & Development Expense
- 11.5.5 Recent strategies and developments:
- 11.5.5.1 Partnerships, Collaborations, and Agreements:
- 11.5.5.2 Product Launches and Product Expansions:
- 11.5.5.3 Acquisition and Mergers:
- 11.5.6 SWOT Analysis
- 11.6 Cleerly, Inc.
- 11.6.1 Company Overview
- 11.6.2 Recent strategies and developments:
- 11.6.2.1 Partnerships, Collaborations, and Agreements:
- 11.7 Vista AI, Inc.
- 11.7.1 Company Overview
- 11.8 Viz.ai, Inc.
- 11.8.1 Company Overview
- 11.8.2 Recent strategies and developments:
- 11.8.2.1 Partnerships, Collaborations, and Agreements:
- 11.8.2.2 Product Launches and Product Expansions:
- 11.9 RSIP Vision Ltd.
- 11.9.1 Company Overview
- 11.10. GE HealthCare Technologies, Inc.
- 11.10.1 Company Overview
- 11.10.2 Financial Analysis
- 11.10.3 Segmental and Regional Analysis
- 11.10.4 Research & Development Expenses
- 11.10.5 Recent strategies and developments:
- 11.10.5.1 Product Launches and Product Expansions:
- 11.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
- TABLE 2 North America Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
- TABLE 3 Partnerships, Collaborations and Agreements- Artificial Intelligence In Cardiology Market
- TABLE 4 Product Launches And Product Expansions- Artificial Intelligence In Cardiology Market
- TABLE 5 Acquisition and Mergers- Artificial Intelligence In Cardiology Market
- TABLE 6 Key Customer Criteria - Artificial Intelligence In Cardiology Market
- TABLE 7 North America Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
- TABLE 8 North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- TABLE 9 North America Hardware Market by Country, 2021 - 2024, USD Million
- TABLE 10 North America Hardware Market by Country, 2025 - 2032, USD Million
- TABLE 11 North America Software Market by Country, 2021 - 2024, USD Million
- TABLE 12 North America Software Market by Country, 2025 - 2032, USD Million
- TABLE 13 North America Services Market by Country, 2021 - 2024, USD Million
- TABLE 14 North America Services Market by Country, 2025 - 2032, USD Million
- TABLE 15 North America Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
- TABLE 16 North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- TABLE 17 North America Diagnosis Market by Country, 2021 - 2024, USD Million
- TABLE 18 North America Diagnosis Market by Country, 2025 - 2032, USD Million
- TABLE 19 North America Prediction Market by Country, 2021 - 2024, USD Million
- TABLE 20 North America Prediction Market by Country, 2025 - 2032, USD Million
- TABLE 21 North America Drug Discovery Market by Country, 2021 - 2024, USD Million
- TABLE 22 North America Drug Discovery Market by Country, 2025 - 2032, USD Million
- TABLE 23 North America Other Application Market by Country, 2021 - 2024, USD Million
- TABLE 24 North America Other Application Market by Country, 2025 - 2032, USD Million
- TABLE 25 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
- TABLE 26 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- TABLE 27 North America Ischemic Heart Disease /CAD Market by Country, 2021 - 2024, USD Million
- TABLE 28 North America Ischemic Heart Disease /CAD Market by Country, 2025 - 2032, USD Million
- TABLE 29 North America Cardiac Arrhythmias Market by Country, 2021 - 2024, USD Million
- TABLE 30 North America Cardiac Arrhythmias Market by Country, 2025 - 2032, USD Million
- TABLE 31 North America Heart Failure Market by Country, 2021 - 2024, USD Million
- TABLE 32 North America Heart Failure Market by Country, 2025 - 2032, USD Million
- TABLE 33 North America Other Medical Condition Market by Country, 2021 - 2024, USD Million
- TABLE 34 North America Other Medical Condition Market by Country, 2025 - 2032, USD Million
- TABLE 35 North America Artificial Intelligence In Cardiology Market by Country, 2021 - 2024, USD Million
- TABLE 36 North America Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
- TABLE 37 US Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
- TABLE 38 US Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
- TABLE 39 US Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
- TABLE 40 US Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- TABLE 41 US Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
- TABLE 42 US Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- TABLE 43 US Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
- TABLE 44 US Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- TABLE 45 Canada Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
- TABLE 46 Canada Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
- TABLE 47 Canada Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
- TABLE 48 Canada Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- TABLE 49 Canada Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
- TABLE 50 Canada Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- TABLE 51 Canada Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
- TABLE 52 Canada Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- TABLE 53 Mexico Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
- TABLE 54 Mexico Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
- TABLE 55 Mexico Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
- TABLE 56 Mexico Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- TABLE 57 Mexico Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
- TABLE 58 Mexico Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- TABLE 59 Mexico Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
- TABLE 60 Mexico Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- TABLE 61 Rest of North America Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
- TABLE 62 Rest of North America Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
- TABLE 63 Rest of North America Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
- TABLE 64 Rest of North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- TABLE 65 Rest of North America Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
- TABLE 66 Rest of North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- TABLE 67 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
- TABLE 68 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- TABLE 69 Key Information - IDOVEN S.L.
- TABLE 70 Key Information - Ultromics Ltd.
- TABLE 71 Key Information - CardiAI Inc.
- TABLE 72 Key Information - Tempus AI, Inc.
- TABLE 73 Key Information - Koninklijke Philips N.V.
- TABLE 74 Key Information - Cleerly, Inc.
- TABLE 75 Key Information - Vista AI, Inc.
- TABLE 76 Key Information - Viz.ai, Inc.
- TABLE 77 Key Information - RSIP Vision Ltd.
- TABLE 78 Key Information - GE HealthCare Technologies, Inc.
LIST OF FIGURES
- FIG 1 Methodology for the research
- FIG 2 North America Artificial Intelligence In Cardiology Market, 2021 - 2032, USD Million
- FIG 3 Key Factors Impacting Artificial Intelligence In Cardiology Market
- FIG 4 KBV Cardinal Matrix
- FIG 5 Market Share Analysis, 2024
- FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
- FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov - 2025, Apr) Leading Players
- FIG 8 Porter Five Forces Analysis - Artificial Intelligence In Cardiology Market
- FIG 9 Value Chain Analysis of Artificial Intelligence In Cardiology Market
- FIG 10 Key Customer Criteria - Artificial Intelligence In Cardiology Market
- FIG 11 North America Artificial Intelligence In Cardiology Market share by Component, 2024
- FIG 12 North America Artificial Intelligence In Cardiology Market share by Component, 2032
- FIG 13 North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
- FIG 14 North America Artificial Intelligence In Cardiology Market share by Application, 2024
- FIG 15 North America Artificial Intelligence In Cardiology Market share by Application, 2032
- FIG 16 North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
- FIG 17 North America Artificial Intelligence In Cardiology Market share by Medical Condition, 2024
- FIG 18 North America Artificial Intelligence In Cardiology Market share by Medical Condition, 2032
- FIG 19 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
- FIG 20 North America Artificial Intelligence In Cardiology Market share by Country, 2024
- FIG 21 North America Artificial Intelligence In Cardiology Market share by Country, 2032
- FIG 22 North America Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
- FIG 23 Recent strategies and developments: Ultromics Ltd.
- FIG 24 Recent strategies and developments: Tempus AI, Inc.
- FIG 25 SWOT Analysis: Tempus AI, Inc.
- FIG 26 Recent strategies and developments: Koninklijke Philips N.V.
- FIG 27 SWOT Analysis: Koninklijke Philips N.V.
- FIG 28 Recent strategies and developments: Viz.ai, Inc.
- FIG 29 SWOT Analysis: GE HealthCare Technologies, Inc.
